Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells

American Journal of Pathology

Volumn 157, Issue 3, 2000, Pages 795-803

  Nakashiro, K I ^a   Okamoto, M ^a   Hayashi, Y ^a   Oyasu, R ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; SCATTER FACTOR;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN SECRETION;

EID: 0034490943     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64593-2     Document Type: Article

References (36)

1. Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells
2. Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study
3. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6
4. Interaction between prostatic fibroblast and epithelial cells in culture: Role of androgen
5. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo
6. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
7. Prostate and bone fibroblasts induce human prostate cancer growth in vivo: Implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis
8. Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation
9. Reconstruction of prostatic acinus-like structure from ventral and dorsolateral prostatic epithelial cells of the rat in three-dimensional collagen gel matrix culture
10. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma
11. Keratinocyte growth factor expression in hormone insensitive prostate cancer
12. Activation-induced expression of vascular permeability factor by human peripheral T cells: A non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay
13. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions
14. Down-regulation of TSC-22 (transforming growth factor β-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo
15. Control of hepatocyte replication by two serum factors
16. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats
17. Partial characterization of a hepatocyte growth factor from rat platelets
18. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells
19. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer
20. Hepatocyte growth factor/scatter factor expression in human mammary epithelium
21. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma
22. Expression of scatter factor and c-met receptor in benign and malignant breast tissue
23. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer
24. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
25. Transforming growth factor-β and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells
26. Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor
27. Expression of scatter factor in human bladder carcinoma
28. c-met proto-oncogene expression in benign and malignant human prostate tissues
29. Establishment and characterization of a human carcinoma cell line (PC-3)
30. Androgen receptors in endocrine-therapy-resistant human prostate cancer
31. Distant metastases from prostatic carcinoma express androgen receptor protein
32. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer
33. Co-expression of hepatocyte growth factor and its receptor in human prostate cancer
34. A new human prostate carcinoma cell line, 22Rv1
35. Role of HGF/c-Met system in human prostate cancer progression
36. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor